Z94.8 C80 C96 D47 D56 D57
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who underwent allogeneic or autologous hematopoietic stem cell transplantation at the University Children's Hospital Tübingen between January 1, 2013 and December 31, 2021.
Exclusion criteria
Exclusion criteria: Patients with permanently impaired oral food intake prior to hematopoietic stem cell transplantation (e.g. dependence on gastrostomy feeding), known congenital or acquired gastrointestinal malformations or previous gastrointestinal resection, and pre-existing inflammatory bowel disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between pre-transplant nutritional status (body mass index [BMI] percentile) and changes in BMI percentile up to day +200 after hematopoietic stem cell transplantation and the occurrence of transplant-related complications. Transplant-related complications include acute and chronic graft-versus-host disease (GvHD), sinusoidal obstruction syndrome (SOS/VOD), mucositis, bacterial, viral and invasive fungal infections, BK virus-associated cystitis, and graft failure. Outcomes are retrospectively assessed using pseudonymized routine clinical data from hospital admission until day +200 after HSCT. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival, transplant-related mortality, time to engraftment, changes in body weight, height and BMI percentiles during follow-up, duration of hospitalization, and the frequency of microbiological pathogens detected in stool, blood and urine samples, including their association with nutritional status and transplant-related complications. | — |
Countries
Germany
Contacts
Universitätsklinikum Tübingen